In our study, it was overexpressed in recurrent and non-recurrent cancer tissues, as was the case with KLK4. Another study (15) also found KLK4 to be significantly expressed in 55% of ovarian cancer tissue samples. This evidence concerns the gene KLK4 and ovarian cancer.